Rac1 prevents cisplatin-induced apoptosis through down-regulation of p38 activation in NIH3T3 cells

FEBS Lett. 2002 May 8;518(1-3):129-34. doi: 10.1016/s0014-5793(02)02674-1.

Abstract

In this study, the role of V12-Rac1 in the cisplatin-induced apoptosis was investigated. Cisplatin-induced apoptosis is associated with cytochrome c release, which can be inhibited by V12-Rac1 expression. The analysis of mitogen-activated protein kinase activity indicated that V12-Rac1 expression led to a decrease in p38 activity after exposure to cisplatin but not c-jun N-terminal kinase and extracellular signal-regulated kinase. Using pharmacological inhibitors, it was found that only p38 is a critical mediator in the cisplatin-induced apoptosis of NIH3T3 cells. This suggests that V12-Rac1 can stimulate the anti-apoptotic signaling pathway in response to cisplatin, and that decreased p38 activity caused by V12-Rac1 expression in cisplatin-treated NIH3T3 cells is crucial for V12-Rac1-dependent cell survival.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells
  • Animals
  • Antineoplastic Agents / antagonists & inhibitors*
  • Apoptosis*
  • Cisplatin / antagonists & inhibitors*
  • Cytochrome c Group / metabolism
  • Down-Regulation
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • JNK Mitogen-Activated Protein Kinases
  • Mice
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism*
  • Mitogen-Activated Protein Kinases / physiology
  • Mutation
  • p38 Mitogen-Activated Protein Kinases
  • rac1 GTP-Binding Protein / genetics
  • rac1 GTP-Binding Protein / physiology*

Substances

  • Antineoplastic Agents
  • Cytochrome c Group
  • Enzyme Inhibitors
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • rac1 GTP-Binding Protein
  • Cisplatin